ZLAB Q2 2022 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+30.4% YoY

Gross Profit

$31M63.9% margin

Operating Income

-$99M-204.9% margin

Net Income

-$138M-286.3% margin

EPS (Diluted)

$-14.40

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$49M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$207M

Stockholders' Equity

$1.2B

Cash & Equivalents

$681M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$37M	+30.4%
Gross Profit	$31M	-$116M	+126.5%
Operating Income	-$99M	-$171M	+42.1%
Net Income	-$138M	-$163M	+15.5%

Revenue Segments

Zejula

$34M72%

Optune

$12M24%

Nuzyra

$1M3%

Qinlock

$623,0001%